-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

711. Cell Collection and Manufacturing of HSPCs, CAR-T Cells, and Other Cellular Therapy Products: Poster III

Symposia: Cell Collection and Manufacturing of HSPCs, CAR-T Cells, and Other Cellular Therapy Products Program: Oral and Poster Abstracts
Type: Poster
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Zhaozhao Chen, Doctor1*, Anqi Ren, Master1,2*, Jinhui Shu, Master3*, Yingying Li4,5*, Hekuan Huang, Bachelor2,3*, Yu Hu3,4* and Heng Mei, Doctor1*

1Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, 中国, China
2Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China
4Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
5Hubei Clinical and Research Centre of Thrombosis and Haemostasis, Wuhan, China

Ruchi P. Patel, PhD1,2, Trang Vu, PhD2*, Dean Qian, M.S.2*, Yunlin Zhang, MS1*, Guido Ghilardi, MD1*, Steven Yang, M.D, Ph.D.2*, Stefan K. Barta, MD3, Nicholas A. Siciliano, PhD2*, Adam E. Snook, PhD2,4* and Marco Ruella, MD1

1Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
2Vittoria Biotherapeutics, Philadelphia, PA
3Abramson Cancer Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
4Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA

Ilaria Pisani1*, Giusi Melita1*, Simone Naso1*, Michele Francesco Quaroni2*, Giada Matera2*, Daniela Belotti2*, Benedetta Cabiati2*, Elisa Gotti3*, Carolina Cuofano3*, Chiara Capelli3*, Jolanda Sarno1*, Angela Maria Savino4*, Ilaria Ratti5*, Daniele Prati5*, Benedetta Rambaldi6*, Giorgio Ottaviano7*, Giovanna Lucchini7*, Giuseppe Dastoli1*, Andrea Biondi1,8, Alessandro Rambaldi9, Josee Golay3*, Martino Introna3*, Giuseppe Gaipa1,2 and Sarah Tettamanti, PhD1*

1Tettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
2Laboratorio di Terapia Cellulare e Genica Stefano Verri, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
3Centro di Terapia Cellulare "G. Lanzani", Bergamo, Italy
4Department of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy
5Department of Transfusion Medicine and Hematology, Milano Cord Blood Bank, Processing Facility and Biobank POLI-MI, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy
6Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy
7Department of Pediatrics, Bone Marrow Transplant Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
8Pediatrics Department, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
9Department of Oncology and Hematology, University of Milan and ASST Papa Giovanni XXIII, Bergamo, Italy

Gunjan L. Shah, MD1,2,3, Karlo Perica, MD, PhD4, Katherine Nagel, NP5*, Erica Payson5*, Kinga K. Hosszu, PhD6*, David J. Chung, MD, PhD1,2,3, Heather J. Landau, MD1,2,3, Michael Scordo, MD1,2,3, Malin Hultcrantz, MD3,7, Neha Korde, MD3,8, Kylee H Maclachlan, PhD, BSc, FRACP, FRCPA3,7, Urvi A. Shah, MD3,7, Carlyn Rose Tan, MD3,7, Hamza Sloan Hashmi, MD9*, Alexander M. Lesokhin, MD2,3,7, Sridevi Rajeeve, MD2,3,7*, Saad Z. Usmani, MD1,2,3,8, Sham Mailankody, MD, MBBS2,3 and Sergio A. Giralt, MD1,2,3

1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Medicine, Weill Cornell Medical College, New York, NY
4Cellular Therapy Service, Memorial Sloan Kettering, New York, NY
5Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
6Department of Pediatrics, Immune Discovery and Modeling Service, Memorial Sloan Kettering Cancer Center, New York, NY
7Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
8Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
9Myeloma Service, Department of Medicine, Memorial Sloan Kettering, New York, NY

Hiroshi Yasui, MD, PhD1,2, Keiji Hirano3*, Asako Kobayashi1*, Lihua Li, PhD1*, Takuya Takahashi3*, Margarita Artemenko, MD, PhD3*, Naotaka Noda, PhD3*, Daichi Sadato, PhD4*, Kyoko Haraguchi, MD, PhD5*, Ayako Arai, MD, PhD2, Kohzoh Imai, MD, PhD6*, Noriko Doki7, Masatoshi Yanagida, PhD3* and Tomohiro Ishigaki, MD, PhD8*

1The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan
2Department of Hematology and Oncology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan
3Central Research Laboratories, Sysmex Corporation, Kobe, Japan
4Clinical Research and Trials Center, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
5Division of Transfusion and Cell Therapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-ku, Tokyo, Japan
6Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan
7Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
8Department of Laboratory Medicine, IMSUT Hospital, The Institute of Medical Science, The University of Tokyo, Minato-Ku, Tokyo, JPN

Devki D. Sukhtankar, PhD*, Thomas Cayton*, Ashley Chin*, Christian Ramos*, Kanchan G Jhaver, Ph.D.*, Nina Caculitan, PhD* and Pina M. Cardarelli, Ph.D.

GPCR Therapeutics, Redwood City, CA

Alexandra Dreyzin, MD, MS1,2*, Yihua Cai, PhD1*, Kyu Lee Han, PhD1*, Michaela Prochazkova, PhD1*, Jennifer Webb, MD3, Keri Toner, MD3, Kathryn Bushnell, MS3*, Bonnie Yates, NP2*, Ping Jin, MD, MS1*, David F. Stroncek, MD, MS1 and Nirali N. Shah, MD4

1Center for Cellular Engineering, National Institutes of Health Clinical Center, Bethesda, MD
2Pediatric Oncology Branch, National Institutes of Health, Bethesda, MD
3Children's National Hospital, Washington, DC
4Pediatric Oncology Branch, NIH, Bethesda, MD

Hans Layman1*, Belinda Jackson2*, Natalya Belkina, PhD2*, Sripriya Ranganathan, PhD2* and Jacob N Wohlstadter2*

1Meso Scale Diagnostics, LLC, Pacifica, CA
2Meso Scale Diagnostics, LLC, Rockville, MD

Ao Zhang1*, Yingying Wu, MD2*, Chunyan Sun3*, Fang Liu1*, Tao Guo1*, Guohui Cui1*, Heng Mei1*, Jing He1*, Min Zhang1*, Chun Zhang1*, Qiuling Wu1*, Wenjun He1*, Zhipeng Chen1*, Fei Zhao3*, Lin Liu1*, Bo Zhang1*, Lu Zhang1*, Danying Liao1*, Yu Hu3*, Linghui Xia4* and Jun Fang1*

1Department of Haematology, Institute of Hematology, Union Hospital, Tongji Medical School, Huazhong University of Science and Technology, Wuhan, China
2Department of Haematology, Institute of Hematology, Union Hospital, Tongji Medical School, Huazhong University of Science and Technology, Wuhan, Hubei, China
3Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
4Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Biping Deng, MS1*, Zhaoli Liu1*, Xiaoming Qu1*, Yu'e Zhang1*, Zhongxin Zhang1*, Rong Luan, phD1*, Lingli Zhang, MS1*, Ming Ma1*, Xiai Wu1*, Rui Liu2*, Alex H. Chang3*, Kai Hu, MD2 and Chunrong Tong, MD4*

1Cytology Laboratory, Beijing GoBroad Boren Hospital, Beijing, China
2Department of Lymphoma and Myeloma Research Center, Beijing Gobroad Hospital, Beijing, China
3Shanghai YaKe Biotechnology Ltd, Shanghai, China
4Department of Hematology, Beijing GoBroad Boren Hospital, Beijing, China

Marcel Teichert1*, Keven Hörster, Dr. rer. nat.1*, Sarah Flossdorf2*, Christine Hanoun1*, Ulrike Buttkereit, Dr. rer. medic.1*, Richard Noppeney, MD1*, Hans Christian Reinhardt, MD1 and Bastian von Tresckow1

1Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer consortium (DKTK partner site Essen), University Hospital Essen, University of Duisburg-Essen, Essen, Germany
2Institute for Medical Informatics, Biometry and Epidemiology (IMIBE), University of Duisburg-Essen, Essen, Germany

Nina Caculitan, PhD1*, GaYeon Kim2*, Ann Woolfrey3*, Luke P. Akard, MD4, Ah-Reum Jeong, MD5, Jack Khouri, MD6, Gunjan L. Shah, MD7 and Pina M. Cardarelli, Ph.D.1

1GPCR Therapeutics, Redwood City, CA
2GPCR Therapeutics, Inc., Seoul, Korea, Republic of (South)
3Medpace, Cincinnati, OH
4Indiana Blood and Marrow Transplantation, Franciscan Health, Indianapolis, IN
5UCSD Moores Cancer Center, La Jolla, CA
6Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
7Transplant and Cellular Therapy Services, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

*signifies non-member of ASH